# Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

> clinical trial · VERIFIED · 2026-07-14

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Berger Disease

- Company: Novartis Pharmaceuticals
- Sector: Berger Disease
- Primary source: https://clinicaltrials.gov/study/NCT07498335

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.